| Pharmalgen |
103970 |
001 |
351(a) |
Venoms, Mixed Vespid Venom Protein |
For Injection |
Subcutaneous |
300UG/ML |
Multi-Dose Vial |
1991/10/08
|
ALK - Abello A/S |
Disc |
Voluntarily Revoked |
|
N/A |
| Pharmalgen |
103970 |
002 |
351(a) |
Venoms, Mixed Vespid Venom Protein |
For Injection |
Intradermal |
300UG/ML |
Multi-Dose Vial |
1991/10/08
|
ALK - Abello A/S |
Disc |
Voluntarily Revoked |
|
N/A |
| Pharmalgen |
103971 |
001 |
351(a) |
Venoms, Wasp Venom Protein |
For Injection |
Subcutaneous |
100UG/ML |
Multi-Dose Vial |
1991/10/08
|
ALK - Abello A/S |
Disc |
Voluntarily Revoked |
|
N/A |
| Pharmalgen |
103971 |
002 |
351(a) |
Venoms, Wasp Venom Protein |
For Injection |
Intradermal |
100UG/ML |
Multi-Dose Vial |
1991/10/08
|
ALK - Abello A/S |
Disc |
Voluntarily Revoked |
|
N/A |
| Pharmalgen |
103972 |
001 |
351(a) |
Venoms, White Faced Hornet Venom Protein |
For Injection |
Subcutaneous |
100UG/ML |
Multi-Dose Vial |
1991/10/08
|
ALK - Abello A/S |
Disc |
Voluntarily Revoked |
|
N/A |
| Pharmalgen |
103972 |
002 |
351(a) |
Venoms, White Faced Hornet Venom Protein |
For Injection |
Intradermal |
100UG/ML |
Multi-Dose Vial |
1991/10/08
|
ALK - Abello A/S |
Disc |
Voluntarily Revoked |
|
N/A |
| Pharmalgen |
103973 |
001 |
351(a) |
Venoms, Yellow Hornet Venom Protein |
For Injection |
Subcutaneous |
100UG/ML |
Multi-Dose Vial |
1991/10/08
|
ALK - Abello A/S |
Disc |
Voluntarily Revoked |
|
N/A |
| Pharmalgen |
103973 |
002 |
351(a) |
Venoms, Yellow Hornet Venom Protein |
For Injection |
Intradermal |
100UG/ML |
Multi-Dose Vial |
1991/10/08
|
ALK - Abello A/S |
Disc |
Voluntarily Revoked |
|
N/A |
| Pharmalgen |
103974 |
001 |
351(a) |
Venoms, Yellow Jacket Venom Protein |
For Injection |
Subcutaneous |
100UG/ML |
Multi-Dose Vial |
1991/10/08
|
ALK - Abello A/S |
Disc |
Voluntarily Revoked |
|
N/A |
| Pharmalgen |
103974 |
002 |
351(a) |
Venoms, Yellow Jacket Venom Protein |
For Injection |
Intradermal |
100UG/ML |
Multi-Dose Vial |
1991/10/08
|
ALK - Abello A/S |
Disc |
Voluntarily Revoked |
|
N/A |
| Novolin N |
019959 |
001 |
351(a) |
insulin isophane human |
Injectable Suspension |
Subcutaneous |
1,000UNITS/10ML (100UNITS/ML) |
Multi-Dose Vial |
1991/07/01
|
Novo Nordisk Inc. |
OTC |
Licensed |
N/A |
N/A |
| Novolin N |
019959 |
002 |
351(a) |
insulin isophane human |
Injectable Suspension |
Subcutaneous |
300UNITS/3ML (100UNITS/ML) |
Autoinjector |
1991/07/01
|
Novo Nordisk Inc. |
OTC |
Licensed |
N/A |
N/A |
| Survanta |
020032 |
001 |
351(a) |
beractant |
Suspension |
Intratracheal |
100MG/4ML (25MG/ML) |
Single-Dose Vial |
1991/07/01
|
AbbVie Inc. |
Rx |
Licensed |
N/A |
N/A |
| Survanta |
020032 |
002 |
351(a) |
beractant |
Suspension |
Intratracheal |
200MG/8ML (25MG/ML) |
Single-Dose Vial |
1991/07/01
|
AbbVie Inc. |
Rx |
Licensed |
N/A |
N/A |
| Novolin R |
019938 |
001 |
351(a) |
insulin human |
Injection |
Subcutaneous |
1,000UNITS/10ML (100UNITS/ML) |
Multi-Dose Vial |
1991/06/25
|
Novo Nordisk Inc. |
OTC |
Licensed |
N/A |
N/A |
| Novolin 70/30 |
019991 |
001 |
351(a) |
insulin isophane human and insulin human |
Injection |
Subcutaneous |
300UNITS/10ML (30UNITS/ML); 700UNITS/10ML (70UNITS/ML) |
Multi-Dose Vial |
1991/06/25
|
Novo Nordisk Inc. |
OTC |
Licensed |
N/A |
N/A |
| Leukine |
103362 |
001 |
351(a) |
sargramostim |
For Injection |
Intravenous, Subcutaneous |
250MCG |
Single-Dose Vial |
1991/03/05
|
Partner Therapeutics, Inc. |
Rx |
Licensed |
N/A |
N/A |
| Leukine |
103362 |
002 |
351(a) |
sargramostim |
Injection |
Intravenous, Subcutaneous |
500MCG/ML |
Multi-Dose Vial |
1991/03/05
|
Partner Therapeutics, Inc. |
Disc |
Licensed |
N/A |
N/A |
| Neupogen |
103353 |
001 |
351(a) |
filgrastim |
Injection |
Intravenous, Subcutaneous |
300MCG/ML |
Single-Dose Vial |
1991/02/20
|
Amgen Inc. |
Rx |
Licensed |
N/A |
N/A |
| Neupogen |
103353 |
002 |
351(a) |
filgrastim |
Injection |
Intravenous, Subcutaneous |
480MCG/1.6ML |
Single-Dose Vial |
1991/02/20
|
Amgen Inc. |
Rx |
Licensed |
N/A |
N/A |